Allergan, working to fend off a hostile approach from Valeant Pharmaceuticals, is reportedly taking a look at the smaller Salix Pharmaceuticals, weighing a multibillion-dollar deal that could render it unattainable–or at least drive up its asking price.

…read more

Source: Could buying Salix get Valeant off of Allergan’s scent?


0 No comments